1th Annual Norman R. Seay Lecture
“Advances in Biotechnology: The Benefits for Underserved Populations
Charles F. & Joanne Knight Alzheimer’s Disease Research Center
Department of Neurology, Washington University School of Medicine
John C. Morris, M.D., Director & Principal Investigator
Reception immediately following sponsored by The Links, Incorporated, Saint Louis Chapter
About the Lecturer
Donna Masterman, M.D., M.S.
Associate Group Medical Director,
Genentech, South San Francisco, California
Dr. Masterman is Associate Group Medical Director at Genentech, Inc., a member of the Roche Group in South San Francisco, California. Dr. Masterman obtained her MD and MS in Physiology and Biophysics from the University of Washington where she also completed an internship in Internal Medicine. Dr. Masterman went on to train in Neurology at UCLA, where she also completed fellowship training in Behavioral Neurology and Movement Disorders. Dr. Masterman then joined the faculty in Neurology at UCLA, where she was the Clinical Core Leader of the Alzheimer Disease Research Center from 1998 to 2003. She then joined the biotech industry, working at Amgen, Inc., as a Global Development and Global Regulatory leader in many areas, including Alzheimer and Parkinson disease.
Since 2007, Dr. Masterman has worked at Genentech, where she currently is the Associate Group Medical Director, US Medical Affairs Neuroscience, and Senior Medical Director, US Medical Affairs Neurosciences. She leads the Ocrelizumab cross-functional team and pro-vides direction and mentorship to medical directors/medical scientists. Dr. Masterman also provides leadership for the Medical Science Liaisons within the Neuroscience Medical Affairs organization and facilitates strategic partnerships with therapeutic area experts, patient groups, and scientific institutions to enable optimal collaboration for medical products throughout their lifecycles. Dr. Masterman has served as a National Institute on Health re-viewer, as well as serving on the Board of Directors of the American Society for Experimental Neurotherapeutics and her local Alzheimer Association Chapter.